DCF — MERCYONE CLINTON MEDICAL CENTER
Enterprise Value: $-335.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-335.2M
Enterprise Value
$-103.0M
PV of Cash Flows
$-232.2M
PV of Terminal Value
$-374.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $119.6M | $-22.5M | -19.0% | $-27.6M | $-25.1M |
| Year 2 | $123.1M | $-22.0M | -18.0% | $-27.2M | $-22.5M |
| Year 3 | $126.8M | $-21.4M | -17.0% | $-26.7M | $-20.1M |
| Year 4 | $130.6M | $-21.4M | -16.0% | $-26.9M | $-18.4M |
| Year 5 | $134.6M | $-21.7M | -16.0% | $-27.4M | $-17.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-335.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$116.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.19352060105104485
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5